- Previous Close
96.30 - Open
97.50 - Bid 96.10 x --
- Ask 96.20 x --
- Day's Range
96.20 - 99.50 - 52 Week Range
73.20 - 144.00 - Volume
844,247 - Avg. Volume
660,806 - Market Cap (intraday)
6.906B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
32.61 - EPS (TTM)
2.95 - Earnings Date --
- Forward Dividend & Yield 2.53 (2.39%)
- Ex-Dividend Date Jul 26, 2024
- 1y Target Est
153.00
SciVision Biotech Inc. engages in the production and sale of hyaluronic acid medical products in Taiwan and internationally. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It is also involved in the wholesale of medical equipment; and provides management consulting services. The company was founded in 1990 and is based in Kaohsiung, Taiwan.
www.scivision.com.twRecent News: 1786.TW
View MorePerformance Overview: 1786.TW
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1786.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1786.TW
View MoreValuation Measures
Market Cap
6.91B
Enterprise Value
6.28B
Trailing P/E
32.61
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.73
Price/Book (mrq)
3.79
Enterprise Value/Revenue
7.56
Enterprise Value/EBITDA
18.96
Financial Highlights
Profitability and Income Statement
Profit Margin
26.18%
Return on Assets (ttm)
6.41%
Return on Equity (ttm)
13.31%
Revenue (ttm)
815.25M
Net Income Avi to Common (ttm)
213.44M
Diluted EPS (ttm)
2.95
Balance Sheet and Cash Flow
Total Cash (mrq)
861.28M
Total Debt/Equity (mrq)
13.53%
Levered Free Cash Flow (ttm)
227.46M